Okaperidon
| |
| Nazivi | |
|---|---|
| IUPAC naziv
3-[2-[4-(6-Fluoro-1,2-benzoksazol-3-il)piperidin-1-il]etil]-2,9-dimetilpirido[1,2-a]pirimidin-4-on
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C24H25FN4O2 | |
| Molarna masa | 420,49 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Okaperidon je benzizoksazolni antipsihotik.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Leysen, JE; Janssen, PM; Gommeren, W; Wynants, J; Pauwels, PJ; Janssen, PA (1992). „In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone”. Molecular pharmacology. 41 (3): 494—508. PMID 1372084.
